In heart failure, the heart can no longer supply the body with enough blood. The condition often develops over many years, ...
Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...
From the traditional view, the hemodynamic point of view, HF is defined as a pathophysiologic condition in which impaired cardiac performance is responsible for the heart's inability, at normal ...
Heart failure has increasingly been recognized as a complex, metabolism-driven syndrome that extends far beyond traditional models of hemodynamic ...
A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication ...
AB-1002 is an investigational one-time gene therapy administered directly to the heart to promote production of a modified version (I-1c) of the naturally occurring protein inhibitor-1, designed to ...
Ischemic heart disease, the leading cause of death in the United States, has long puzzled researchers. While high serum cholesterol levels are linked to cardiovascular risk, the role of dietary fat ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...